|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.980 JOD | +5.32% |
|
+18.56% | +23.75% |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
| 04-27 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 14.85M 20.95M 18.31M 16.9M 15.57M 29.35M 2.02B 30M 202M 79.43M 988M 78.68M 76.95M 3.4B | P/E 2024 |
13.7x | P/E 2025 | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 14.78M 20.86M 18.23M 16.82M 15.5M 29.22M 2.01B 29.87M 201M 79.06M 984M 78.32M 76.6M 3.39B | EV / Sales 2024 |
1.32x | EV / Sales 2025 | 1.3x |
| Free-Float |
7.27% | Yield 2024 |
4.67% | Yield 2025 | - |
| 1 day | +5.32% | ||
| 1 week | +18.56% | ||
| Current month | +18.56% | ||
| 1 month | +18.56% | ||
| 3 months | +32.00% | ||
| 6 months | +25.32% | ||
| Current year | +23.75% |
| 1 week | 1.76 | 1.98 | |
| 1 month | 1.71 | 1.98 | |
| Current year | 1.5 | 1.98 | |
| 1 year | 1.46 | 1.98 | |
| 3 years | 1.34 | 1.98 | |
| 5 years | 1.28 | 1.98 | |
| 10 years | 1.28 | 3.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ashraf Hussein
CEO | Chief Executive Officer | 44 | 01/01/2013 |
Rima Shanoudeh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Belal Salameh
DFI | Director of Finance/CFO | 50 | 01/01/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Munther Hussein
CHM | Chairman | 58 | - |
| Director/Board Member | 61 | 01/09/2016 | |
| Director/Board Member | 64 | 01/01/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.32% | +18.56% | +33.78% | +46.67% | 20.95M | ||
| -0.90% | -0.15% | +14.11% | +81.10% | 48.15B | ||
| -0.23% | -1.65% | +67.15% | +112.03% | 35.59B | ||
| -0.76% | -1.44% | -4.29% | +37.63% | 11.9B | ||
| -0.88% | -0.62% | +17.31% | +89.97% | 11.85B | ||
| +0.19% | +2.87% | +34.92% | +139.73% | 9.31B | ||
| +3.37% | -0.10% | +51.64% | -3.75% | 7.02B | ||
| -0.75% | -0.91% | +17.45% | +37.70% | 6.91B | ||
| -2.25% | -2.08% | +0.45% | +209.99% | 6.55B | ||
| -9.93% | +0.35% | -31.51% | +16.58% | 6.13B | ||
| Average | -0.68% | +1.84% | +20.10% | +76.76% | 14.34B | |
| Weighted average by Cap. | -0.88% | -0.42% | +26.79% | +86.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.76M 12.36M 10.8M 9.97M 9.19M 17.32M 1.19B 17.7M 119M 46.87M 583M 46.43M 45.41M 2.01B | 9.17M 12.94M 11.3M 10.43M 9.62M 18.12M 1.25B 18.53M 125M 49.04M 610M 48.58M 47.52M 2.1B |
| Net income | 822K 1.16M 1.01M 935K 862K 1.62M 112M 1.66M 11.17M 4.39M 54.67M 4.35M 4.26M 188M | 1.01M 1.42M 1.24M 1.14M 1.05M 1.99M 137M 2.03M 13.67M 5.38M 66.88M 5.33M 5.21M 230M |
| Net Debt | 334K 471K 411K 380K 350K 659K 45.33M 674K 4.54M 1.78M 22.2M 1.77M 1.73M 76.42M | -67.69K -95.49K -83.45K -77.01K -70.98K -134K -9.2M -137K -920K -362K -4.5M -359K -351K -15.5M |
Employees
129
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | JOD 1.980 | +5.32% | 6 |
| 15/07/26 | JOD 1.880 | +7.43% | 1,721 |
- Stock Market
- Stocks
- PHIL Stock
Select your edition
All financial news and data tailored to specific country editions
















